^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    MabionCD20 (rituximab biosimilar)

    Associations
    News
    Trials
    Company:
    HB Human BioSci, Mabion
    Drug class:
    CD20 inhibitor
    Related drugs:
    Associations
    News
    Trials